Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder—Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes

Intravesical botulinum toxin type A (BoNT-A) injection has been recognized as the standard treatment for refractory overactive bladder (OAB). However, its therapeutic efficacy and safety have not been thoroughly reviewed in elderly patients. This study aims to provide treatment outcomes for patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Yin-Chien, Kao, Yao-Lin, Ho, Yi-Hui, Wu, Kuan-Yu, Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967532/
https://www.ncbi.nlm.nih.gov/pubmed/36828410
http://dx.doi.org/10.3390/toxins15020095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967532/
https://www.ncbi.nlm.nih.gov/pubmed/36828410
http://dx.doi.org/10.3390/toxins15020095

Ejemplares similares